---
figid: PMC3910500__nihms530933f6
figtitle: 'Canonical PI3K and MAPK pathway activation determined by reverse phase
  protein arrays and compared between GBM subclasses: Proneural (P, purple, n=55)
  and Mesenchymal (M, red, n=45)'
organisms:
- NA
pmcid: PMC3910500
filename: nihms530933f6.jpg
figlink: /pmc/articles/PMC3910500/figure/F6/
number: F6
caption: 'Canonical PI3K and MAPK pathway activation determined by reverse phase protein
  arrays and compared between GBM subclasses: Proneural (P, purple, n=55) and Mesenchymal
  (M, red, n=45). Activation/expression levels are plotted for principal signaling
  nodes of the MAPK (phospho-MEK and phospho-p90RSK), PI3 kinase (pS473-Akt) and mTOR
  (TSC1/2, phospho-mTOR, p235/236 S6, phospho-4EBP1 and EIF4E) pathways (p-values,
  two-tailed T-test). Mesenchymal tumors showed increased activation of the MAPK pathway
  (evidenced by higher levels of phospho-MEK and downstream phospho-p90RSK) and decreased
  levels of phospho-ERK inhibitory target TSC2. In contrast, proneural tumors showed
  relatively elevated expression and activation of members of the PI(3) kinase pathway
  including Akt PDK1 target site threonine 308 (p=0.01, not shown) and Akt mTORC2
  target site (serine 473). Phospho-ERK levels were not significantly different between
  these two subtypes.'
papertitle: The Somatic Genomic Landscape of Glioblastoma.
reftext: Cameron W. Brennan, et al. Cell. ;155(2):462-477.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9086314
figid_alias: PMC3910500__F6
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3910500__F6
ndex: 1bb5ddce-df07-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3910500__nihms530933f6.html
  '@type': Dataset
  description: 'Canonical PI3K and MAPK pathway activation determined by reverse phase
    protein arrays and compared between GBM subclasses: Proneural (P, purple, n=55)
    and Mesenchymal (M, red, n=45). Activation/expression levels are plotted for principal
    signaling nodes of the MAPK (phospho-MEK and phospho-p90RSK), PI3 kinase (pS473-Akt)
    and mTOR (TSC1/2, phospho-mTOR, p235/236 S6, phospho-4EBP1 and EIF4E) pathways
    (p-values, two-tailed T-test). Mesenchymal tumors showed increased activation
    of the MAPK pathway (evidenced by higher levels of phospho-MEK and downstream
    phospho-p90RSK) and decreased levels of phospho-ERK inhibitory target TSC2. In
    contrast, proneural tumors showed relatively elevated expression and activation
    of members of the PI(3) kinase pathway including Akt PDK1 target site threonine
    308 (p=0.01, not shown) and Akt mTORC2 target site (serine 473). Phospho-ERK levels
    were not significantly different between these two subtypes.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Dsor1
  - Mtk
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pdk1
  - Raf
  - Akt
  - rl
  - gig
  - Tsc1
  - Crtc
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4E1
  - eIF4EHP
  - Thor
  - S6k
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IRS1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - TSC2
  - TSC1
  - CCL26
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPTOR
  - EIF4E
  - EIF4E2
  - EIF4E3
  - EIF4EBP1
  - RPS6KB1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
